mRNA vaccine fill/finish is very similar to biologics, however depending on the formulation, the CDMO may require ...

Reliably manufacturing consistent LNPs was another challenge, and producing the raw materials needed to make the particles is a limiting factor in the production of COVID-19 vaccines today.

Lipid nanoparticle (LNP) mRNA vaccines emerged during the COVID-19 pandemic to form an almost miraculous protection against a virus, which killed millions around the world. Aided by expedited ...

Cambridge, Massachusetts-based Alnylam sued Pfizer and BioNTech in 2022, alleging their COVID-19 vaccines infringed patents ...

The global lipid nanoparticles market is on the cusp of remarkable expansion, projected to grow at a CAGR of 14% through 2035, according to a recent industry analysis. Estimated to generate USD 1,144.

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Scientists have developed a method for analysing the structure of lipid nanoparticles that could be used to improve vaccine ...

A new PEARLS article in PLoS Pathogens reviews the rapid evolution and pandemic potential of emerging influenza A viruses, ...

A team led by scientists at the University of Nottingham's School of Pharmacy demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen tiny lipid nanoparticles to reveal the ...